Technical Analysis for SOLY - Soliton, Inc.

Grade Last Price % Change Price Change
grade D 12.08 -6.57% -0.85
SOLY closed down 6.57 percent on Friday, July 19, 2019, on 33 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
7 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical SOLY trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -6.57%

Older signals for SOLY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
Soliton, Inc. is a pre-revenue stage medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. The Company is based in Houston, Texas, and is actively engaged in bringing this device to the market. The Company expects to file for premarket clearance with the U.S. Food and Drug Administration ("FDA") for its first device in the first quarter of 2019 and expects to receive clearance to market the device in mid-2019.
Health Medical Device Platform Technology
Is SOLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 15 Why Soliton Stock Is Falling Today
Jul 15 CIR, CPE and GLPG among midday movers
Jul 15 Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate Long-Term Improvement
Jul 11 AIR, CI and OMCL among midday movers
Jul 11 Healthcare - Top 5 Gainers / Losers
Jul 10 Soliton Expands Clinical Trial Sites to include SkinCare Physicians
Jul 9 A Look At Benzinga Pro's Most-Searched Tickers For July 9, 2019
Jul 9 Adamis Pharmaceuticals and AAC Holdings among healthcare gainers; Karyopharm Therapeutics leads the losers
Jul 9 SOLY, NOAH among premarket losers
Jul 8 Mid-Afternoon Market Update: Dow Down 150 Points; Intra-Cellular Therapies Shares Plunge
See more SOLY news...
Indicators
Indicator Value
52 Week High 29.0
52 Week Low 4.12
Average Volume 2,309,941
200-Day Moving Average 0.0
50-Day Moving Average 14.1402
20-Day Moving Average 15.005
10-Day Moving Average 16.188
Average True Range 2.2919
ADX 22.8
+DI 27.8386
-DI 26.1868
Chandelier Exit (Long, 3 ATRs ) 15.0943
Chandelier Exit (Short, 3 ATRs ) 18.1757
Upper Bollinger Band 19.8677
Lower Bollinger Band 10.1423
Percent B (%b) 0.2
BandWidth 64.814395
MACD Line -0.1222
MACD Signal Line 0.3549
MACD Histogram -0.4771
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.97
Resistance 3 (R3) 14.16 13.71 13.66
Resistance 2 (R2) 13.71 13.23 13.62 13.55
Resistance 1 (R1) 12.90 12.93 12.68 12.71 13.44
Pivot Point 12.45 12.45 12.34 12.36 12.45
Support 1 (S1) 11.64 11.97 11.42 11.45 10.72
Support 2 (S2) 11.19 11.67 11.10 10.61
Support 3 (S3) 10.38 11.19 10.51
Support 4 (S4) 10.19